The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; Mylan; Novartis; Pfizer; Roche
Speakers' Bureau - Gilead Sciences; Lilly; Mylan; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Lilly; Novartis; Pfizer; Roche
miRNA signatures of prognostic significance in single hormone receptor-positive breast cancer.
 
Elzbieta Senkus-Konefka
Stock and Other Ownership Interests - AstraZeneca/Merck; Elly Health; Pfizer
Honoraria - Cancerodigest; Curio Science; Egis Pharmaceuticals; Genomic Health; Gilead Sciences; High5md; Lilly; Novartis; Oncompass; Pfizer
Consulting or Advisory Role - AstraZeneca; Egis Pharmaceuticals; Genomic Health; Gilead Sciences; Lilly; Novartis; Oncompass; Pfizer
Research Funding - Amgen; AstraZeneca; Lilly; Novartis; Pfizer; Roche; Samsung
Travel, Accommodations, Expenses - Egis Pharmaceuticals; Novartis; Pfizer; Roche
 
Marta Popęda
No Relationships to Disclose
 
Michał Kunc
No Relationships to Disclose
 
Michał Bieńkowski
No Relationships to Disclose
 
Marcin Braun
Employment - Medicover
Travel, Accommodations, Expenses - Roche
 
Aleksandra Lacko
No Relationships to Disclose
 
Barbara Radecka
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Lilly; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Lilly; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Lilly; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; SERVIER
Research Funding - Amgen; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Lilly; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; SERVIER
Expert Testimony - Amgen; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Lilly; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; SERVIER
 
Joanna Pikiel
No Relationships to Disclose
 
Maria Litwiniuk
No Relationships to Disclose
 
Katarzyna Pogoda
Honoraria - Amgen; AstraZeneca; Egis Pharmaceuticals; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Teva; Vipharm
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Gilead Sciences; Lilly; Novartis
Speakers' Bureau - AstraZeneca; Gilead Sciences; Lilly; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
 
Ewa Iżycka-Świeszewska
No Relationships to Disclose
 
Anna Joanna Zaczek
No Relationships to Disclose
 
Wojciech Biernat
No Relationships to Disclose